A new treatment developed by Israeli researchers could change how epilepsy is managed by not only reducing seizures but also helping protect the brain from long-term damage, according to the Hebrew University of Jerusalem. Scientists say this compound helps brain cells handle chemical stress and control inflammation — two factors believed to play a major role in triggering seizures and harming brain function over time. In laboratory testing, TXM-CB3 reduced harmful intracellular stress and shifted immune activity toward a more protective direction. In preclinical models, early treatment delayed when seizures began, reduced their frequency, and improved the patient’s memory and behavior. When the treatment was introduced later, it still reduced seizures but had less impact on cognitive difficulties.